Latest News

Webcasts Strategies to Increase the Value of Drug Therapy

Strategies to Increase the Value of Drug Therapy

Value is a concept that concerns all healthcare stakeholders.

Webcasts Deconstructing Script Abandonment: New Perspectives on Why Patients Don't Fill

Deconstructing Script Abandonment: New Perspectives on Why Patients Don't Fill

In this webinar Zitter Health Insights will deconstruct script abandonment and provide you key findings around the impact on patient outcomes.

Agency Maybe You Shouldn't Hire a VP of Digital Strategy

Maybe You Shouldn't Hire a VP of Digital Strategy

Agencies struggle to find VPs of digital strategy (or multichannel strategy or engagement strategy) because they don't really need one.

Pharmaceutical

Merck will evaluate Keytruda cancer combo therapy

Merck will collaborate with Syndax to evaluate the pairing of an anti-PD-1 therapy in Keytruda with HDAC inhibitor entinostat.

Pharmaceutical

Bayer expands MIT/Harvard collaboration

The focus will now include cardiovascular disease.

Pharmaceutical Five things for pharma marketers to know: Tuesday, March 31

Five things for pharma marketers to know: Tuesday, March 31

Pfizer spent over $1 billion on ads last year; Monday's M&A activity accounted for about 25% of this year's total; Actavis is selling its Australian generics business

Webcasts Mobile Apps Relieve Confusion for All Hospital- Goers—Yes, Even Grandpa

Mobile Apps Relieve Confusion for All Hospital- Goers—Yes, Even Grandpa

In this webinar, we'll discuss how mobile apps are changing the healthcare journey for patients and visitors from all walks of life.

Pharmaceutical Teva will acquire Auspex to fill Copaxone patent hole

Teva will acquire Auspex to fill Copaxone patent hole

The drugmaker known for its massive presence in generics purchased Auspex Pharmaceuticals to bolster its growing specialty business.

Pharmaceutical Horizon makes $1.1-billion rare-disease push

Horizon makes $1.1-billion rare-disease push

Horizon Pharma's purchase of Hyperion Therapeutics will add two rare-disease drugs to its portfolio.

Pharmaceutical

White House "superbug" plan has five-year goal

The White House's National Action Plan for Reducing Antibiotic-Resistant Bacteria proposal includes $1.2 billion in funding to reduce superbug infections and develop new diagnostics.

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.